Latest FDA Drug GMP Warning Letters Target CEOs, Contract Manufacturers
This article was originally published in The Tan Sheet
Executive Summary
Six of FDA's last nine drug GMP warning letters went to contract manufacturing facilities, including firms making OTC drugs and dietary supplements.